Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

13 results
Display

A Study of Prevalence of Activated Protein C Resistance and Leiden Mutation among Korean Patients with Venous Ulcers

Kim JW, Kim SY, Lee CJ, Kim SR

  • KMID: 2086589
  • Korean J Dermatol.
  • 2002 Oct;40(10):1203-1211.
BACKGROUND: Recently, resistance to activated protein C(APC) is known to be an important risk factor for venous leg ulcers. Leiden mutation in clotting factor V is the most common genetic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis

Kim TW, Kim WK, Lee JH, Kim SB, Kim SW, Suh C, Lee KH, Lee JS, Seo EJ, Chi HS, Kim SH

Activated protein C (APC) is a naturally occurring anticoagulant that interacts with factor V and VIII to inhibit the clotting cascade. The prevalence of APC resistance among Korean patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Activated Protein C Resistance and Factor V Leiden Mutation in Patients with Arterial Ischemic Stroke

Byun SJ, Lee TG, Lee JW, Chang DI, Chung KC

  • KMID: 2342822
  • J Korean Neurol Assoc.
  • 2000 Jul;18(4):390-393.
BACKGROUND: In the western hemisphere, resistance to activated protein C (APCR) is the most common risk factor for venous thromboembolic disease. A one-point mutation in the coagulation factor V that...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiphospholipid Antibodies and Activated Protein C Resistance in Patients with Leg Ulcers

Kim JW, Kim SY, Kim KJ, Lee CJ, Cho BG, Lee KH

  • KMID: 2086184
  • Korean J Dermatol.
  • 1999 Feb;37(2):133-140.
BACKGROUND: Antiphospholipid antibodies(APA) including anticardiolipin antibodies(ACA) are significantly associated with ulcerations of the leg. Moreover, resistance to activated protein C(aPC) may be an important risk factor in leg ulcerations. Until...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Study on the Factor V Leiden Mutation in Pregnant Women and Relationship with Preeclampsia Severe Form

Lee JL, Lee SG, Lee JJ, Lee HH, Chung JK, Choi KY, Lee IS, Lee KH

  • KMID: 2140604
  • Korean J Perinatol.
  • 2002 Dec;13(4):406-412.
OBJECTIVE: A study showed that resistance to activated protein C may develope some cases of severe preeclampsia. A common missense mutation in the factor V gene, the Leiden mutation, is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The prevalence of hereditary thrombophilia in the Trakya region of Turkey

Demir M, Vural O, Sunar H, Altun A, Yorulmaz F, Ozbay G

The prevalences of deficiencies in antithrombin III (AT III), protein C (PC), protein S (PS) and in the activated protein C (APC) resistance in the thrombotic population of the Trakya...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Coagulopathies and Ischemic Stroke

Chang DI

  • KMID: 1635921
  • J Korean Neurol Assoc.
  • 2003 Aug;21(4):329-333.
The etiology of ischemic stroke remains undetermined in nearly 40% of patients despite extensive evaluations. Coagulopathies associated with cerebrovascular ischemia may be familial or acquired and account for 4% of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
First Korean case of factor V Leiden mutation in pregnant woman with a history of recurrent pregnancy loss

Han SH, Seo JJ, Kim ES, Ryu JS, Hong SH, Hwang SY

Thrombophilia refers to inherited or acquired hemostatic disorders that result in a predisposition to blood clot formation. When combined with the hypercoagulable state that is characteristic of pregnancy, there is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characteristics of Deep Vein Thrombosis in Patients Under the Age of 40

Huh S, Kwun SH, Kim YW

  • KMID: 1941124
  • J Korean Soc Vasc Surg.
  • 2003 May;19(1):62-67.
PURPOSE: The risk factors and clinical characteristics in young patients with deep venous thrombosis (DVT) were analyzed. METHOD: The clinical characteristics of the 118 patients registered at our DVT clinic, from...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes of Coagulability after Off-pump CABG: Comparison with On-pump CABG

Chang WI, Kim KB, Kim WS, Chung CH, Huh JH, Chang JM, Lee DS, Han KS

  • KMID: 1878300
  • Korean J Thorac Cardiovasc Surg.
  • 2004 Mar;37(3):245-251.
BACKGROUND: Hemostatic function is regarded to be preserved after an off-pump coronary artery bypass grafting (CABG), compared to conventional CABG, and the preserved hemostatic function may increase thrombotic occlusion of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Coagulation Abnormalities in Behcet's Disease

Kang SW, Shin KC, Lee YJ, Lee EB, Baek HJ, Kim HA, Song YW

  • KMID: 2101997
  • J Korean Rheum Assoc.
  • 1999 Sep;6(3):227-237.
OBJECTIVE: The predominant histopathologic lesion in Behcet's disease is vasculitis. Thrombotic complications have been reported in approximately 10-40% of patients with Behcet's disease, but the precise mechanisms are not known....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factor V Leiden Gene Mutation in Femoral Head Osteonecrosis

Kim SY, Suh JS, Park EK, Jung WB, Kim JW, Koo KH, Kim CY

  • KMID: 2104916
  • J Korean Orthop Res Soc.
  • 2003 Oct;6(2):259-264.
PURPOSE: The purpose of the present study was to evaluate the potential association of the G1691A mutation of factor V (factor V Leiden), which is a main causative factor of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inherited Risk Factors for Venous Thrombosis : A Single Institution Experience

Kim HJ, Yang SE, Kim TW, Seo EJ, Lee JH, Yoo B, Lee SD, Yoon YH, Kim SK, Chi HS, Kim SH, Kim WK

  • KMID: 2083430
  • Korean J Hematol.
  • 2001 Feb;36(1):71-78.
BACKGROUND: Venous thromboembolism is a serious medical problem causing considerable morbidity and mortality. Risk factors of thrombosis are surgery, trauma, pregnancy, tumor, oral contraceptive as well as genetic risk factors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr